This company listing is no longer active
PRLX Stock Overview
Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that provide remote communication, diagnosis, treatment, and monitoring of patients.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Parallax Health Sciences, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | n/a |
3 Year Change | -99.90% |
5 Year Change | -99.96% |
Change since IPO | -99.82% |
Recent News & Updates
Recent updates
Shareholder Returns
PRLX | US Healthcare Services | US Market | |
---|---|---|---|
7D | 0% | -0.2% | 1.3% |
1Y | n/a | 2.8% | 29.8% |
Return vs Industry: Insufficient data to determine how PRLX performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how PRLX performed against the US Market.
Price Volatility
PRLX volatility | |
---|---|
PRLX Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 10.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PRLX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PRLX's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | n/a | n/a | https://www.parallaxhealthsciences.com |
Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that provide remote communication, diagnosis, treatment, and monitoring of patients. The company offers remote healthcare products, including patent pending software and mobile apps, and other services, as well as electronic kits and devices from third-party licensed platforms that are designated towards a patient’s primary health concern, such as diabetes, blood pressure, cardiovascular, general monitoring, etc.; and audio and video options that interface with the patient’s healthcare providers. It also provides prescription medication dosage monitoring services; and behavioral health products comprising REBOOT, a proprietary behavioral health technology for an individual or an organization to transform the cost of treating and managing chronic illnesses that include pulmonary-COPD-asthma, diabetes, and cardiovascular diseases by effecting the modification of behavior in patients being treated for these chronic diseases.
Parallax Health Sciences, Inc. Fundamentals Summary
PRLX fundamental statistics | |
---|---|
Market cap | US$25.10k |
Earnings (TTM) | -US$12.87m |
Revenue (TTM) | US$128.60k |
0.0x
P/S Ratio0.0x
P/E RatioIs PRLX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PRLX income statement (TTM) | |
---|---|
Revenue | US$128.60k |
Cost of Revenue | US$16.83k |
Gross Profit | US$111.77k |
Other Expenses | US$12.98m |
Earnings | -US$12.87m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did PRLX perform over the long term?
See historical performance and comparison